Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
World J Surg ; 42(3): 632-638, 2018 03.
Article in English | MEDLINE | ID: mdl-29282507

ABSTRACT

BACKGROUND: Transection injury to the recurrent laryngeal nerve (RLN) has been associated with permanent vocal fold palsy, and treatment has been limited to voice therapy or local treatment of vocal folds. Microsurgical repair has been reported to induce a better function. The calcium channel antagonist nimodipine improves functional recovery after experimental nerve injury and also after cranial nerve injury in patients. This study aims to present voice outcome in patients who underwent repair of the RLN and received nimodipine during regeneration. METHODS: From 2002-2016, 19 patients were admitted to our center with complete unilateral injury to the RLN and underwent microsurgical repair of the RLN. After nerve repair, patients received nimodipine for 2-3 months. Laryngoscopy was performed repeatedly up to 14 months postoperatively. The Voice Handicap Index (VHI) was administered, and patients' maximum phonation time (MPT) was recorded during the follow-up. RESULTS: All patients recovered well after surgery, and nimodipine was well tolerated with no dropouts. None of the patients suffered from atrophy of the vocal fold, and some patients even showed a small ab/adduction of the vocal fold on the repaired side with laryngoscopy. During long-term follow-up (>3 years), VHI and MPT normalized, indicating a nearly complete recovery from unilateral RLN injury. CONCLUSIONS: In this cohort study, we report the results of the first 19 consecutive cases at our center subjected to reconstruction of the RLN and adjuvant nimodipine treatment. The outcome of the current strategy is encouraging and should be considered after iatrogenic RLN transection injuries.


Subject(s)
Calcium Channel Blockers/therapeutic use , Nimodipine/therapeutic use , Recurrent Laryngeal Nerve Injuries/surgery , Vocal Cord Paralysis/physiopathology , Voice/physiology , Adult , Cohort Studies , Combined Modality Therapy , Female , Humans , Laryngoscopy , Male , Microsurgery , Middle Aged , Nerve Regeneration , Neurosurgical Procedures , Phonation , Plastic Surgery Procedures , Recovery of Function , Recurrent Laryngeal Nerve Injuries/complications , Thyroidectomy/adverse effects , Vocal Cord Paralysis/etiology
2.
Child Care Health Dev ; 38(2): 196-203, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21535083

ABSTRACT

BACKGROUND: Prior studies have examined the impact of preterm birth on the quality of the attachment relationship to the mother in infancy, but few have examined extremely preterm born infants and almost no data have been reported on prematurity and its impact on the attachment organization attained after childhood. METHODS: Thirty-nine adolescents born extremely preterm and 39 full-term born control participants were assessed with the Adult Attachment Interview. RESULTS: The prematurely born showed lower scores regarding measures of attachment security and, in particular, a higher proportion of insecure dismissive patterns. This difference seemed to be clear and persistent even when controlled for intelligence and socio-economic variables. CONCLUSIONS: Because insecure attachment as well as prematurity may be considered as significant risk factors for developing psychopathology, they deserve careful attention in future research and clinical follow-ups.


Subject(s)
Adolescent Behavior/psychology , Mother-Child Relations , Premature Birth/psychology , Adolescent , Adult , Female , Humans , Male , Object Attachment , Psychopathology , Reactive Attachment Disorder/psychology , Risk Factors
3.
Spinal Cord ; 50(4): 315-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22182851

ABSTRACT

STUDY DESIGN: Pilot study. OBJECTIVES: The aim of the study was to develop a neurophysiological method to diagnose the cranial as well as the caudal level of a complete thoracic spinal cord injury (SCI) with higher precision than today's protocols. SETTING: SCI unit Karolinska University Hospital, Stockholm, Sweden. METHODS: Bipolar needle electromyography was recorded in intercostal spaces of five patients with chronic, complete thoracic SCI. Tests were performed during rest, during voluntary activation and during activation of lower body spasticity. Magnetic resonance imaging (MRI) was performed in each patient according to a protocol optimized for imaging near metal implants. RESULTS: Three distinct patterns were found in each patient. Above the lesion we found voluntary activated, normal motor unit potentials (MUPs). At the neurological level and a varying number of segments below, denervated intercostal segments with fibrillation potentials and positive sharp waves appeared. Below the neurological level, normal MUP activated in concert with lower body spasticity was found. The number of denervated segments showed a significant correlation to the length of spinal cord discontinuity on MRI (r=0.97, P<0.05). CONCLUSION: Intercostal neurophysiology in combination with MRI optimized for imaging near metal implants can be used to determine the extent of a chronic complete thoracic SCI, both anatomically and functionally. The described method increases the sensitivity to detect delicate neurological changes related to the dynamic of the pathology that follows SCI and may be useful in analyzing outcome in clinical trials.


Subject(s)
Electromyography/methods , Magnetic Resonance Imaging/methods , Motor Neuron Disease/diagnosis , Paraplegia/diagnosis , Spinal Cord Injuries/diagnosis , Spinal Cord/pathology , Adolescent , Adult , Chronic Disease , Disability Evaluation , Humans , Intercostal Muscles/innervation , Intercostal Muscles/physiopathology , Male , Middle Aged , Motor Neuron Disease/etiology , Motor Neuron Disease/physiopathology , Motor Neurons/physiology , Muscle Spasticity/diagnosis , Muscle Spasticity/etiology , Muscle Spasticity/physiopathology , Neuromuscular Junction/physiopathology , Paraplegia/etiology , Paraplegia/physiopathology , Pilot Projects , Predictive Value of Tests , Prostheses and Implants/standards , Spinal Cord/physiopathology , Spinal Cord Injuries/complications , Thoracic Vertebrae/injuries , Thoracic Vertebrae/pathology , Trauma Severity Indices , Young Adult
4.
Ann Biol Clin (Paris) ; 51(1): 19-26, 1993.
Article in English | MEDLINE | ID: mdl-8338253

ABSTRACT

This report describes a system for real-time biospecific interaction analysis, using biosensor technology based on the optical phenomenon surface plasmon resonance. The biospecific interface is a sensor chip consisting of a thin gold film deposited on a glass support and covered with a hydrogel matrix. One component of the interaction being studied is attached covalently to the hydrogel, and other interactants are passed over the chip in solution. The interaction is followed in real time in terms of changes in the mass concentration of biomolecules at the sensor surface. Surface concentrations down to 10 pg/mm2 can be measured. The technique does not require molecular labels such as isotopes or spectroscopic markers, and purification of interacting components can often be avoided. Repeated analyses can be performed on the same sensor chip. With this system, the same general procedure can be used for a wide range of different applications, including concentration determination, kinetic measurements and multi-site binding studies. The sensitivity of the technique can be adjusted by choice of reagents and experimental procedure: determination of specific proteins in serum down to 20 ng/ml and macromolecular association constants from 10(7) M-1 up to 4 x 10(11) M-1 are documentated examples. No other single analytical system has the same versatility and general applicability to biospecific interaction analysis. The system is developed and marketed by Pharmacia Biosensor AB, Sweden.


Subject(s)
Biosensing Techniques , Polymerase Chain Reaction/methods , Spectrum Analysis/instrumentation , Spectrum Analysis/methods , Technology
5.
J Clin Microbiol ; 29(4): 798-804, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1890180

ABSTRACT

The polymerase chain reaction (PCR) has many potential applications in the field of nucleic acid diagnostics. In particular, it has been successfully applied to the detection of pathogens present in low copy numbers such as the human immunodeficiency virus type 1. Here we describe a time-resolved fluorescence-based hybridization assay which, combined with the PCR, offers an extremely sensitive method for the detection of nucleic acids. In this assay format, the PCR is run by standard procedures and the subsequent hybridization reaction is carried out in solution by using two oligonucleotide probes, one biotinylated and one labeled with europium (Eu3+). The sandwich hybrids are then collected onto a streptavidin-coated microtitration well, and the bound Eu3+ is measured in a time-resolved fluorometer. This assay is rapid, user friendly, and quantitative and lends itself to automation. The application of this assay to the detection of human immunodeficiency virus type 1 is described.


Subject(s)
Acquired Immunodeficiency Syndrome/diagnosis , HIV-1/isolation & purification , Polymerase Chain Reaction , Base Sequence , Cells, Cultured , DNA, Viral/analysis , Fluorometry , HIV-1/genetics , Humans , Kinetics , Molecular Sequence Data , Nucleic Acid Hybridization , Sensitivity and Specificity
6.
J Mol Recognit ; 3(5-6): 208-14, 1990.
Article in English | MEDLINE | ID: mdl-1710913

ABSTRACT

Surface plasmon resonance (SPR) detection requires no labeling of antigen or antibodies and allows quantification of two or more interacting molecular species. The automated SPR instrument used here consists of an optical detection unit, an integrated liquid handling unit, and an autosampler. A first molecule is immobilized to the dextran modified surface of the sensor chip. By sequential introduction, the stepwise formation of multimolecular complexes can then be monitored. A two-site binding assay which allows characterization of MoAb epitope specificities is described. A polyclonal rabbit anti-mouse IgG1 (RAMG1) immobilized to the dextran surface is used to capture the first MoAb from unprocessed hybridoma culture supernatants. After introducing the antigen, the ability of a second MoAb to bind to the antigen is tested. The analysis cycle which is fully automated can be performed more than 100 times using the same RAMG1 surface. Since the detection principle allows monitoring of each reactant in the consecutive formation of a multimolecular complex, multi-site binding experiments can be performed. Five MoAbs recognizing different epitopes on an antigen were shown to bind sequentially, forming a hexamolecular complex. MoAbs were further characterized by inhibition analysis using synthetic peptides derived from the primary structure of their antigen. As a model system MoAbs against recombinant HIV-1 core protein p24 were used in all experiments.


Subject(s)
Antibodies, Monoclonal/immunology , Antigen-Antibody Reactions , Epitopes/immunology , Gene Products, gag/immunology , HIV Antigens/immunology , Viral Core Proteins/immunology , Amino Acid Sequence , Antibody Specificity , Biosensing Techniques , Epitopes/chemistry , HIV Core Protein p24 , Molecular Sequence Data , Surface Properties
7.
Scand J Immunol ; 28(6): 645-52, 1988 Dec.
Article in English | MEDLINE | ID: mdl-2466324

ABSTRACT

Anti-mitochondrial autoantibodies (AMA) from patients with primary biliary cirrhosis (PBC) were analysed for fine specificity by immunoblotting and enzyme-linked immunosorbent assay (ELISA). Inhibition ELISA showed that complex I (NADH-ubiquinone reductase) from beef heart mitochondria completely inhibited the binding of AMA to mitochondrial inner membranes (SMP), indicating that the major mitochondrial antigens are located in complex I. Immunoblot analysis of beef heart SMP, complex I and the iron sulphur (IP) subfraction of complex I revealed several antigens, one of which (75 kDa) reacted with all PBC sera but not with the additional autoimmune sera tested. Resolution of SMP or complex I by two-dimensional electrophoresis yielded in both preparations a polypeptide of 75 kDa with an isoelectric point of 6.4, which reacted with PBC serum and with rabbit antisera raised against the 75,000 subunit of complex I. In immunoblot experiments, the antigenicity of the 75,000 polypeptide in SMP, complex I, and the IP subfraction is increased by prior reduction of the sample with mercaptoethanol. This suggests a similarity to the PBC-specific 'M-2' antigen, which is also sensitive to sulphur reagents. The data indicate that the 75 kDa polypeptide of complex I is a major mitochondrial antigen binding AMA in PBC sera, and allows us to identify the location and probable function of the PBC antigen.


Subject(s)
Autoantigens/analysis , Epitopes/immunology , Intracellular Membranes/immunology , Liver Cirrhosis, Biliary/immunology , Mitochondria/immunology , Quinone Reductases/immunology , Animals , Binding Sites, Antibody , Binding, Competitive , Blotting, Western , Cattle , Enzyme-Linked Immunosorbent Assay , Humans , Intracellular Membranes/enzymology , Liver Cirrhosis, Biliary/enzymology , Mitochondria/enzymology , Mitochondria, Heart/immunology , NAD(P)H Dehydrogenase (Quinone)
8.
Scand J Immunol ; 28(2): 157-65, 1988 Aug.
Article in English | MEDLINE | ID: mdl-2457935

ABSTRACT

Primary biliary cirrhosis (PBC)-specific antigens were purified from beef heart mitochondria by immunoaffinity chromatography. Three major polypeptides (75, 60, and 40 kDa) were detected in the purified antigen fraction both by Coomassie blue staining and by western blot analysis. The 75 kDa antigen was identified as a subunit of Complex I (NADH-ubiquinone reductase) by the following criteria: (1) antibodies against the purified 75 kDa subunit of beef heart Complex I react with the immunoaffinity-purified 75 kDa antigen. (2) the 75 kDa subunit present in isolated Complex I, like that in the immunoaffinity-purified antigen, reacts with PBC sera only after reduction with mercaptoethanol, and (3) the 75 kDa antigen is enriched in isolated Complex I. A relationship between the 75 kDa and the 60 and 40 kDa antigens is suggested, since optimal binding of anti-mitochondrial autoantibodies (AMA) to the latter antigens also requires prior reduction with mercaptoethanol. A fourth major antigen (70 kDa) was also detected by western blot analysis, but only in samples that had not been boiled prior to electrophoresis. This antigen, which is also present in isolated Complex I, resembles the 75, 60, and 40 kDa antigens in its response to mercaptoethanol and its reaction with antibodies against the 75 kDa subunit of Complex I. A scheme is presented which relates all of the PBC antigens to the parent 75 kDa subunit of Complex I, probably as proteolytic products of the latter.


Subject(s)
Liver Cirrhosis, Biliary/immunology , Adipose Tissue, Brown/ultrastructure , Autoantigens/analysis , Epitopes , Humans , Immunosorbent Techniques , Mitochondria, Heart/immunology , Mitochondria, Liver/immunology , Peptide Fragments/immunology
9.
Int Arch Allergy Appl Immunol ; 83(3): 265-70, 1987.
Article in English | MEDLINE | ID: mdl-3298073

ABSTRACT

The antigenic reactivities of circulating IgM- and IgG-type antimitochondrial antibodies (AMA) from 18 patients with primary biliary cirrhosis (PBC) were compared by the use of immunoblotting and enzyme-linked immunosorbent assay (ELISA). In immunoblotting, the binding patterns of IgM and IgG were very similar when F1-ATPase and mitochondria were used as antigens. The major PBC-specific IgM-reactive antigen was identical with the dominating IgG-reactive antigen, sharing the same molecular weight of 70 kD and the same requirement for reduced thiol groups for expression of antigenicity. Other PBC-related mitochondrial proteins with variable antigenicity had the molecular weights of 60 and 43 kD. Depending on the IgM and IgG reactions in F1-ELISA, PBC patients can be grouped into three categories: patients with IgG and IgM (12/18), IgG alone (5/18) and IgM alone (1/18). By serum fractionation, the IgM reactivity was shown to be a true PBC-related antibody antigen reaction, and not due to interference of rheumatoid factors.


Subject(s)
Immunoglobulin M/immunology , Liver Cirrhosis, Biliary/immunology , Mitochondria/immunology , Adult , Aged , Antibody Specificity , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin G/analysis , Immunologic Techniques , Male , Middle Aged
10.
Clin Exp Immunol ; 66(2): 399-405, 1986 Nov.
Article in English | MEDLINE | ID: mdl-3028680

ABSTRACT

The adenine nucleotide translocator protein (ANT) is the first well-characterized mitochondrial polypeptide to be identified as an antigen for antimitochondrial autoantibodies (AMA) in PBC sera. Because of the potential use for a highly purified antigen as a tool in studying the aetiology of PBC, we have undertaken an assessment of the quantitative importance of ANT as a PBC-specific mitochondrial antigen. Immunoblotting and ELISA techniques were used. Both methods reveal PBC antibodies against isolated rat liver ANT. However, competitive ELISA experiments using purified rat liver ANT as the competing antigen show that anti-ANT antibodies in PBC serum comprise only a fraction of the total AMA. Furthermore, both ELISA and immunoblotting experiments show that rat liver ANT is not a specific antigen for PBC autoantibodies. Sera from patients with SLE, chronic active hepatitis, and sera from normal, control patients, have nearly the same, or higher, ANT antibody titres. Thus, ANT is not a good candidate as an antigen for the diagnosis of PBC.


Subject(s)
Autoantigens/analysis , Autoimmune Diseases/immunology , Liver Cirrhosis, Biliary/immunology , Mitochondria, Liver/immunology , Mitochondrial ADP, ATP Translocases/immunology , Nucleotidyltransferases/immunology , Animals , Autoantibodies/analysis , Cattle , Electrophoresis, Polyacrylamide Gel , Humans , Immunoglobulin G/analysis , Liver Cirrhosis, Biliary/diagnosis , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...